The following post was on the Yahoo message board this afternoon.
scribler2000
Date: Feb 3 1999 3:19PM EST
"I just got off the phone from listening to the Block conference call. Many questions that have been raised on this board were answered during the call. The call lasted for approx. 40 mins. and all of the questions (except 2) were about Atrix products. For all of you investors out there who are discouraged and frustrated with recent stock prices. Take heart, things are going well, very well! Don't let negative comments due to the lack of specific numbers sway you. All of the comments about Atrix were very positive, but, they are not going to pin down specific numbers.
Web page - active within a week. Includes instructional video for dental profession, animated video, online ordering, etc. Site also geared toward consumers.
Promotion - Only just begun, the largest push yet to come, including direct mail marketing to dentists, seminars, video. Testing direct consumer marketing and if all goes well direct to consumer marketing will be a big part of future efforts. Sales reps in monthly contact with 4000 periodontists and in semi-monthly contact with dentists whose practice includes significant anmounts of SRP.
Sales - Considerably ahead of schedule! Reps making appointments weeks in advance, sales are way ahead of quotas.
Response of dental professionals - Dentists are much more eager to try Atridox than is traditional for new dental products being introduced, once they try it re-orders are ahead of expectations, dentists are using the product on more patients than anticipated.
Insurance reimbursement - efforts in this area are going well. Presentations to managed health care professionals are well received and the expectation is for Atridox to be widely covered under insurance within the year. No news of patients turning down treatment due to lack of insurance. If patients are refusing treatment it must be small numbers.
Heart disease and perio - Work is being done to incorporate this link into the marketing efforts once all of the facts are in.
Atrisorb - The enthusistic response to Atridox has enhanced the marketing ability for Atrisorb and the new Free Flow Atrisorb to periodontists.
In short. ALL OF THE NEWS IS GOOD! I am sure some you will be able to trun all of this good news into something negative, but, this is the news we've all been waiting for. WE ARE ON OUR WAY FINALLY!"
Block is obviously very excited about Atridox and this should translate into more analysts attention, especially with sales figures beyond expectations. This will only get better as time goes on.
Stock price jumped today after this conference call.
|
